At the Annual NIH Pain Symposium, National Institute on Drug Abuse (NIDA) director Nora Volkow stressed the #RxProblem of medical schools, nursing, and pharmacy schools using pharmaceutical company-provided educational materials for chronic pain diagnosis and opioid prescribing practices.
This conflict of interest could result in improper painkiller prescribing, increased addiction & abuse, and opiate addiction that leads to heroin addiction when pill mills are shut down without proper harm reduction and support programs for addicted individuals.
The problem: Unethical conduct has already occurred, and it is destroying communities, especially in Appalachia.
Fact of the matter, our treatment approach brain health has shown very little progress in the past 40 years.
Lack of knowledge about the true pathophysiology of mental and psychosomatic illness makes these fields subject to heavy publication bias, manipulation of data by drug makers, and improper education of healthcare providers and patients.
The case of Purdue Pharma: Kentucky suit against pill maker
stalled for years (Aggressive, deceptive marketing is charged)
Lawsuit seeks to make drugmaker pay for OxyContin abuse
Kentucky Sued In Federal Court Over Drug Treatment Practices
Chicago Blames Big Pharma for Epidemic Addictions to Painkillers
Santa Clara County sues drug makers for hyping painkillers
To make matters worse, support and harm reduction programs for patient victims have been inadequate or nonexistent, resulting in hepatitis C and HIV epidemics.
conservative politics (here too) tends to brace opposition to full implementation of harm reduction programs like needle exchanges and passing of "Good Samaritan" laws that make intranasal naloxone (Narcan) widely available in communities.